MB BChir, MA(Cantab), FRCS(Urol), PhD
I am a Consultant Urological Surgeon and Lead for Urological Cancer at Maidstone and Tunbridge Wells NHS Trust and specialise in the diagnosis and treatment of prostate cancer and bothersome urinary symptoms caused by enlarged prostate (benign prostatic hyperplasia or BPH). I offer a personalised approach to every patient, tailored to their unique needs.
For men with possible prostate cancer, I would focus on achieving a fast and accurate diagnosis, through the use of multi-parametric MRI and MRI-guided transperineal biopsies.
For men needing cancer treatment I offer nerve-sparing robotic prostate cancer surgery (DaVinci) with functional outcomes aligning with best published results.
I also specialise in the management of BPH, including laser BPH surgery (HoLEP), TURP, and prostate artery embolisation, with exceptionally low complication rates.
I gained my primary medical qualification at Cambridge University and went on to gain a PhD in prostate cancer with UCL supported by a British Urological Foundation Scholarship.
I am a pioneer of transperineal prostate biopsies performed under local anaesthetic and was one of the first in the UK to adopt the new approach. I personally performed more than 1,000 transperineal prostate biopsies and train other urologists at national courses.
I am active in prostate cancer research as a Principal Investigator for the TRANSLATE study which investigates the best method for diagnosing prostate cancer. I am also recognised by my peers as a member of the Editorial Board for BJU International.
My ethos is to offer early and accurate assessment for every patient and achieve the best possible outcome. This may involve timely treatment but in many cases reassurance is all that is required. I also consider patients' experience of their care to be as important as their outcome.
I also held a joint position during clinical training as an Academic Clinical Lecturer at KCL and led novel several translational research projects in prostate and bladder cancer.
I am the current lead for the urgent referral pathways for prostate and bladder cancer in the Trust and also the lead for education in the department.
Some of the principal treatments carried out by Mr Hide Yamamoto at Spire include:
Prostate cancer diagnosis and early treatment:
Benign prostate hyperplasia (prostate enlargement):
MB BChir / University of Cambridge / 2002
Bachelor of Medicine, Bachelor of Surgery
The General Medical Council
The Royal College of Surgeons
British Association of Urological Surgeons
European Association of Urology
Medical Defence Union
I am a reviewer to several peer-review journals including the British Journal of Urology International, the International Journal of Surgery and the Journal of Clinical Urology.